Century Therapeutics Appoints Morgan Conn as New CFO
Company Announcements

Century Therapeutics Appoints Morgan Conn as New CFO

An announcement from Century Therapeutics ( (IPSC) ) is now available.

Century Therapeutics, Inc. gears up for a strategic financial steer as Morgan Conn, Ph.D., takes the helm as Chief Financial Officer starting October 14, 2024. Bringing in a wealth of experience from his tenure at Pharvaris N.V. and PTC Therapeutics, as well as his academic background in chemistry, Dr. Conn is set to receive a comprehensive compensation package including a base salary, performance-based bonus, signing bonus, and equity awards. Dr. Conn’s appointment is fortified with an executive agreement that outlines terms of salary continuation and equity vesting in scenarios of termination with or without cause, aligning his interests with the company’s long-term success.

See more insights into IPSC stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyCentury Therapeutics price target lowered to $5 from $9 at H.C. Wainwright
TipRanks Auto-Generated NewsdeskCentury Therapeutics Reports Q3 Results & Strategic Updates
TheFlyCentury Therapeutics reports Q3 EPS (37c), consensus (45c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App